US2011201666A1PendingUtilityA1
Compounds from mycelium of antrodia cinnamomea and use thereof
Est. expiryJan 28, 2028(~1.5 yrs left)· nominal 20-yr term from priority
A61P 31/14C07D 207/46C07D 207/50C07C 235/34C07D 307/60C07D 207/444A61P 31/20
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to compounds from mycelium of Antrodia cinnamomea . The present invention also relates to a composition and a method for treating or prophylaxis of hepatitis C virus (HCV) infection.
Claims
exact text as granted — not AI-modified1 . A method for treating or prophylaxis hepatitis C virus infection which comprises administering to a subject in need thereof a pharmaceutically effective amount of an active agent selected from
(1) a compound having the formula III
wherein
R is —(CH 2 ) k COOH or —(CH 2 ) k COO(C m H 2m+1 ) wherein k is 0-6 and m is 0-6;
(2) a compound having the formula
wherein
R 1 is C 1-10 carboxylic acid or C 1-10 ester;
R 2 is C 1-10 carboxylic acid or C 1-10 ester;
R 3 is H, C 1-10 alkyl, C 2-10 alkenyl or C 2-10 alkynyl; and
R 4 is H, C 1-10 alkyl, C 2-10 alkenyl or C 2-10 alkynyl;
or
(3) a compound having the formula
wherein
X is N or O;
R 1 is C 1-10 alkyloxy, C 2-10 alkenyloxy, or C 2-10 alkynyloxy;
R 2 is H, C 1-10 alkyl, C 2-10 alkenyl or C 2-10 alkynyl; and
R 3 is absent, H or hydroxy;
provided that if X is O, R 3 is absent.
2 . The method of claim 1 , wherein the compound is selected from
3 . The method according to claim 1 , wherein the subject is a mammal.
4 . The method according to claim 3 , wherein the mammal is a human.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.